Kainic acid-induced activation of nuclear factor-κB in rat hippocampus
暂无分享,去创建一个
[1] Y. Kitamura,et al. Kainic acid induction of heme oxygenase in vivo and in vitro , 1998, Neuroscience.
[2] M. Mattson,et al. Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium Homeostasis* , 1998, The Journal of Biological Chemistry.
[3] Klaus Heese,et al. Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells , 1998, Journal of neurochemistry.
[4] P. Rakic,et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.
[5] M. Mattson,et al. Activation of NF‐κB protects hippocampal neurons against oxidative stress‐induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration , 1997, Journal of neuroscience research.
[6] D. Stephenson,et al. Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. , 1997, Brain research. Molecular brain research.
[7] H. Kimura,et al. In VivoHypoxia-Induced Neuronal Damage with an Enhancement of Neuronal Nitric Oxide Synthase Immunoreactivity in Hippocampus , 1997, Experimental Neurology.
[8] C. Kaltschmidt,et al. NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.
[9] Tatsuo Suzuki,et al. The Effect of Dexamethasone on the Expression of Activated NF-κB in Adjuvant Arthritis , 1997 .
[10] P. Baeuerle,et al. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease , 1997 .
[11] S. Tsirka,et al. An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus , 1997, The Journal of Neuroscience.
[12] M. Memo,et al. Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.
[13] P. Mcgeer,et al. Enhancement of immunoreactivity for NF-κB in human cerebral infarctions , 1996, Brain Research.
[14] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[15] M. Baudry,et al. Seizure Activity Results in a Rapid Induction of Nuclear Factor‐κB in Adult but Not Juvenile Rat Limbic Structures , 1996, Journal of neurochemistry.
[16] D. Graham,et al. Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus , 1996, Brain Research.
[17] G. Rondouin,et al. Release of TNFα in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage , 1996, Neuroreport.
[18] S. Manolagas,et al. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Baeuerle,et al. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] Sidney Strickland,et al. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator , 1995, Nature.
[21] M. Mattson,et al. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[23] A. Salminen,et al. Alteration of transcription factor binding activities in the ischemic rat brain. , 1995, Biochemical and biophysical research communications.
[24] G. Kreutzberg,et al. Microglia: Intrinsic immuneffector cell of the brain , 1995, Brain Research Reviews.
[25] Christian Kaltschmidt,et al. Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis , 1994, Journal of Neuroimmunology.
[26] H. Neumann,et al. Constitutive NF-kappa B activity in neurons , 1994, Molecular and cellular biology.
[27] H. Kimura,et al. Early response of brain resident microglia to kainic acid-induced hippocampal lesions , 1994, Brain Research.
[28] M. Korner,et al. NF‐kappa B activates the HIV promoter in neurons. , 1993, The EMBO journal.
[29] D. Reis,et al. Synthesis of nitric oxide in CNS glial cells , 1993, Trends in Neurosciences.
[30] T. Morgan,et al. TGF-β1 mRNA Increases in Macrophage/Microglial Cells of the Hippocampus in Response to Deafferentation and Kainic Acid-Induced Neurodegeneration , 1993, Experimental Neurology.
[31] D. Dickson,et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.
[32] J. Zimmer,et al. Microglial MHC antigen expression after ischemic and kainic acid lesions of the adult rat hippocampus , 1993, Glia.
[33] D. Walker,et al. Microglia in degenerative neurological disease , 1993, Glia.
[34] M. N. Wallace,et al. Activated astrocytes of the mouse hippocampus contain high levels of NADPH-diaphorase. , 1992, Neuroreport.
[35] A. Contestabile,et al. Antagonists of the NMDA receptor and allopurinol protect the olfactory cortex but not the striatum after intra-cerebral injection of kainic acid , 1992, Brain Research.
[36] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[37] M. Satoh,et al. Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain , 1991 .
[38] C. Scheidereit,et al. Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli , 1991, Molecular and cellular biology.
[39] Takashi Yamaguchi,et al. Convulsants induce interleukin-1β messenger RNA in rat brain , 1990 .
[40] P. Mcgeer,et al. Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions , 1988, Journal of neuroscience research.
[41] M. Rizzo,et al. Blindsight: A case study and implications by L. Weiskrantz, Oxford University Press, 1986. £ 19.50 (viii + 187 pages) ISBN 9 18 852129 4 , 1987, Trends in Neurosciences.
[42] J. Coyle,et al. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors , 1982, Nature.
[43] C. Cotman,et al. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid , 1980, The Journal of comparative neurology.
[44] C. Cotman,et al. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells , 1978, Nature.
[45] T. Chase,et al. Nuclear Factor-κB Contributes to Excitotoxin-Induced Apoptosis in Rat Striatum , 1998 .
[46] I. Adcock,et al. NF-kappa B: a pivotal role in asthma and a new target for therapy. , 1997, Trends in pharmacological sciences.
[47] L. Packer,et al. Redox regulation of NF-kappa B activation. , 1997, Free radical biology & medicine.
[48] J. Coyle,et al. Oxidative stress in neurodegenerative diseases. , 1996, Annual review of pharmacology and toxicology.
[49] P. Baeuerle,et al. Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. , 1995, Biological chemistry Hoppe-Seyler.
[50] S. Miyamoto,et al. REL/NF-?B/I?B Story , 1995 .
[51] I. Verma,et al. Rel/NF-kappa B/I kappa B story. , 1995, Advances in cancer research.
[52] R. Tyrrell,et al. Transient enhancement of heme oxygenase 1 mRNA accumulation: a marker of oxidative stress to eukaryotic cells. , 1994, Methods in enzymology.